tradingkey.logo

ENDRA Life Sciences Inc

NDRA
4.990USD
-0.180-3.48%
Fechamento 11/04, 16:00ETCotações atrasadas em 15 min
3.75MValor de mercado
PerdaP/L TTM

ENDRA Life Sciences Inc

4.990
-0.180-3.48%

Mais detalhes de ENDRA Life Sciences Inc Empresa

ENDRA Life Sciences Inc. is developing an enhanced ultrasound technology platform - Thermo Acoustic Enhanced Ultrasound (TAEUS), a technology which characterizes tissue similar to a magnetic resonance imaging (MRI). The Company's TAEUS technology uses radio frequency (RF) pulses to stimulate tissues, using a small fraction (less than 1%) of the amount of energy that would be transmitted into the body during an MRI scan. The use of RF energy allows its TAEUS technology to penetrate deep into tissue, enabling the imaging of human anatomy at depths equivalent to those of conventional ultrasound. The RF pulses are absorbed by tissue and converted into ultrasound signals. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease (SLD), a chronic liver disease spectrum. It is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

Informações de ENDRA Life Sciences Inc

Código da empresaNDRA
Nome da EmpresaENDRA Life Sciences Inc
Data de listagemJun 28, 2017
CEOMr. Alexander Y. Tokman
Número de funcionários21
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 28
Endereço3600 Green Ct Ste 350
CidadeANN ARBOR
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal48105-2440
Telefone17343350468
Sitehttps://www.endrainc.com/
Código da empresaNDRA
Data de listagemJun 28, 2017
CEOMr. Alexander Y. Tokman

Executivos da empresa ENDRA Life Sciences Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Anthony DiGiandomenico
Mr. Anthony DiGiandomenico
Independent Director
Independent Director
70.81K
+1200.99%
Mr. Michael Milos Thornton
Mr. Michael Milos Thornton
Chief Technology Officer
Chief Technology Officer
20.00
--
Mr. Alexander Y. Tokman
Mr. Alexander Y. Tokman
Chairman of the Board, Acting Chief Executive Officer
Chairman of the Board, Acting Chief Executive Officer
5.00
--
Mr. Michael Harsh
Mr. Michael Harsh
Independent Director
Independent Director
2.00
-99.96%
Mr. Louis J. Basenese
Mr. Louis J. Basenese
Independent Director
Independent Director
--
--
Ms. Yvonne Briggs
Ms. Yvonne Briggs
Investor Relations
Investor Relations
--
--
Mr. Richard Jacroux
Mr. Richard Jacroux
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Anthony DiGiandomenico
Mr. Anthony DiGiandomenico
Independent Director
Independent Director
70.81K
+1200.99%
Mr. Michael Milos Thornton
Mr. Michael Milos Thornton
Chief Technology Officer
Chief Technology Officer
20.00
--
Mr. Alexander Y. Tokman
Mr. Alexander Y. Tokman
Chairman of the Board, Acting Chief Executive Officer
Chairman of the Board, Acting Chief Executive Officer
5.00
--
Mr. Michael Harsh
Mr. Michael Harsh
Independent Director
Independent Director
2.00
-99.96%
Mr. Louis J. Basenese
Mr. Louis J. Basenese
Independent Director
Independent Director
--
--
Ms. Yvonne Briggs
Ms. Yvonne Briggs
Investor Relations
Investor Relations
--
--

Detalhamento da receita

Sem dados
Sem dados
Por Empresa
Por Região
Sem dados

Distribuição de ações

Atualizado em: qui, 30 de out
Atualizado em: qui, 30 de out
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
ATW Partners LLC
9.95%
Lipman (John Carter)
6.52%
DiGiandomenico (Anthony)
6.07%
Geode Capital Management, L.L.C.
0.44%
UBS Financial Services, Inc.
0.40%
Outro
76.62%
Investidores
Investidores
Proporção
ATW Partners LLC
9.95%
Lipman (John Carter)
6.52%
DiGiandomenico (Anthony)
6.07%
Geode Capital Management, L.L.C.
0.44%
UBS Financial Services, Inc.
0.40%
Outro
76.62%
Tipos de investidores
Investidores
Proporção
Individual Investor
12.60%
Private Equity
9.95%
Investment Advisor
0.65%
Investment Advisor/Hedge Fund
0.44%
Corporation
0.06%
Outro
76.31%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
24
12.65K
1.08%
+1.88K
2025Q2
34
22.09K
2.99%
+12.79K
2025Q1
37
5.94K
0.98%
+652.00
2024Q4
38
889.00
0.17%
-4.90K
2024Q3
39
6.39K
8.81%
+5.79K
2024Q2
39
2.03K
9.18%
+1.72K
2024Q1
33
352.00
9.94%
+101.00
2023Q4
35
276.00
9.44%
+68.00
2023Q3
37
286.00
9.99%
+78.00
2023Q2
39
314.00
10.85%
+151.00
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
DiGiandomenico (Anthony)
5.44K
0.72%
+5.38K
+9125.42%
Jun 11, 2025
Geode Capital Management, L.L.C.
5.13K
0.68%
+594.00
+13.09%
Aug 31, 2025
UBS Financial Services, Inc.
4.70K
0.62%
+4.70K
--
Jun 30, 2025
The Vanguard Group, Inc.
116.00
0.02%
--
--
Aug 31, 2025
S.H.N. Financial Investments Ltd
686.00
0.09%
+686.00
--
Jun 04, 2024
Northwestern Mutual Capital, LLC
35.00
0%
+35.00
--
Jun 30, 2025
Thornton (Michael Milos)
20.00
0%
--
--
Mar 24, 2025
BofA Global Research (US)
6.00
0%
+2.00
+50.00%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Nome
Proporção
Sem dados

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Nov 05, 2024
Merger
35→1
Nov 05, 2024
Merger
35→1
Nov 05, 2024
Merger
35→1
Nov 05, 2024
Merger
35→1
Aug 16, 2024
Merger
50→1
Aug 16, 2024
Merger
50→1
Data
Tipo
Proporção
Nov 05, 2024
Merger
35→1
Nov 05, 2024
Merger
35→1
Nov 05, 2024
Merger
35→1
Nov 05, 2024
Merger
35→1
Aug 16, 2024
Merger
50→1
Aug 16, 2024
Merger
50→1
Aug 16, 2024
Merger
50→1
Aug 16, 2024
Merger
50→1
Dec 06, 2022
Merger
20→1
Dec 06, 2022
Merger
20→1
Ver Mais
KeyAI